journal article·2015-01Open access

Loss of monocyte chemoattractant protein-1 alters macrophage polarization and reduces NFκB activation in the foreign body response

Laura Beth Moore, Andrew J. Sawyer, Antonios Charokopos, Eleni A. Skokos, Themis R. Kyriakides

Acta Biomaterialia· Volume 11

Abstract

Implantation of biomaterials elicits a foreign body response characterized by fusion of macrophages to form foreign body giant cells and fibrotic encapsulation. Studies of the macrophage polarization involved in this response have suggested that alternative (M2) activation is associated with more favorable outcomes. Here we investigated this process in vivo by implanting mixed cellulose ester filters or polydimethylsiloxane disks in the peritoneal cavity of wild-type (WT) and monocyte chemoattractant protein-1 (MCP-1) knockout mice. We analyzed classical (M1) and alternative (M2) gene expression via quantitative polymerase chain reaction, immunohistochemistry and enzyme-linked immunosorbent assay in both non-adherent cells isolated by lavage and implant-adherent cells. Our results show that macrophages undergo unique activation that displays features of both M1 and M2 polarization including induction of tumor necrosis factor α (TNF), which induces the expression and nuclear translocation of p50 and RelA determined by immunofluorescence and Western blot. Both processes were compromised in fusion-deficient MCP-1 KO macrophages in vitro and in vivo. Furthermore, inclusion of BAY 11-7028, an inhibitor of NFκB activation, reduced nuclear translocation of RelA and fusion in WT macrophages. Our studies suggest that peritoneal implants elicit a unique macrophage polarization phenotype leading to induction of TNF and activation of the NFκB pathway.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Macrophage Migration Inhibitory Factor · Immune cells in cancer · IL-33, ST2, and ILC Pathways

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (47)

Show source-provided references
1. Macrophage polarization: an opportunity for improved outcomes in biomaterials and regenerative medicine10.1016/j.biomaterials.2012.02.034 ↗
2. Alternative activation of macrophages: mechanism and functions10.1016/j.immuni.2010.05.007 ↗
3. Protective and pathogenic functions of macrophage subsets10.1038/nri3073 ↗
4. Macrophage plasticity and polarization in tissue repair and remodelling10.1002/path.4133 ↗
5. Activation of murine macrophages10.1002/0471142735.im1402s83 ↗
6. Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences10.4049/jimmunol.175.1.342 ↗
7. Macrophage phenotypes during tissue repair10.1189/jlb.1012512 ↗
8. Exploring the full spectrum of macrophage activation10.1038/nri2448 ↗
9. Gene expression profiling of cutaneous wound healing10.1186/1479-5876-5-11 ↗
10. Transcriptional switching in macrophages associated with the peritoneal foreign body response10.1038/icb.2014.19 ↗
11. Foreign body reaction to biomaterials10.1016/j.smim.2007.11.004 ↗
12. Immune responses to implants—a review of the implications for the design of immunomodulatory biomaterials10.1016/j.biomaterials.2011.05.078 ↗
13. On the mechanisms of biocompatibility10.1016/j.biomaterials.2008.04.023 ↗
14. On the nature of biomaterials10.1016/j.biomaterials.2009.07.027 ↗
15. Zwitterionic hydrogels implanted in mice resist the foreign-body reaction10.1038/nbt.2580 ↗
16. Molecular mediators of macrophage fusion10.1016/j.tcb.2009.07.005 ↗
17. Macrophage phenotype as a determinant of biologic scaffold remodeling10.1089/ten.tea.2007.0264 ↗
18. Macrophage phenotype as a predictor of constructive remodeling following the implantation of biologically derived surgical mesh materials10.1016/j.actbio.2011.11.031 ↗
19. Macrophage participation in the degradation and remodeling of extracellular matrix scaffolds10.1089/ten.tea.2008.0419 ↗
20. Functional skeletal muscle formation with a biologic scaffold10.1016/j.biomaterials.2010.06.039 ↗
21. Histomorphometric analysis of the phenotypical differentiation of recruited macrophages following subcutaneous implantation of an allogenous acellular dermal matrix10.1016/j.ijom.2010.10.025 ↗
22. Proangiogenic scaffolds as functional templates for cardiac tissue engineering10.1073/pnas.1006442107 ↗
23. Macrophage phenotypes in the collagen-induced foreign body reaction in rats10.1016/j.actbio.2013.01.022 ↗
24. Lack of TNF-alpha-induced MMP-9 production and abnormal E-cadherin redistribution associated with compromised fusion in MCP-1-null macrophages10.1016/j.ajpath.2011.01.045 ↗
25. Macrophage fusion, giant cell formation, and the foreign body response require matrix metalloproteinase 910.1189/jlb.1008588 ↗
26. Macrophage fusion leading to foreign body giant cell formation persists under phagocytic stimulation by microspheres in vitro and in vivo in mouse models10.1002/jbm.a.32513 ↗
27. Beta1 and beta2 integrins mediate adhesion during macrophage fusion and multinucleated foreign body giant cell formation10.1016/S0002-9440(10)64882-1 ↗
28. Foreign body giant cell formation is preceded by lamellipodia formation and can be attenuated by inhibition of Rac1 activation10.2353/ajpath.2007.061213 ↗
29. Inflammasome components Asc and caspase-1 mediate biomaterial-induced inflammation and foreign body response10.1073/pnas.1105152108 ↗
30. NF-kappaB signaling participates in both RANKL- and IL-4-induced macrophage fusion: receptor cross-talk leads to alterations in NF-kappaB pathways10.4049/jimmunol.1002628 ↗
31. Genetic programs expressed in resting and IL-4 alternatively activated mouse and human macrophages: similarities and differences10.1182/blood-2012-06-436212 ↗
32. Cell-cell signaling in co-cultures of macrophages and fibroblasts10.1016/j.biomaterials.2010.07.101 ↗
33. Localized immunosuppressive environment in the foreign body response to implanted biomaterials10.2353/ajpath.2009.080962 ↗
34. Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappaB10.1073/pnas.0809784106 ↗
35. P50 nuclear factor-kappaB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance10.1158/0008-5472.CAN-06-1867 ↗
36. Shared principles in NF-kappaB signaling10.1016/j.cell.2008.01.020 ↗
37. The intracellular domain of CD44 promotes the fusion of macrophages10.1182/blood-2005-05-1902 ↗
38. Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-kappa B10.1016/S0014-5793(98)01034-5 ↗
39. Transcriptional up-regulation of matrix metalloproteinase-9 expression during spontaneous epithelial to neuroblast phenotype conversion by SK-N-SH neuroblastoma cells, involved in enhanced invasivity, depends upon GT-box and nuclear factor kappaB elements
40. A novel homologous recombination system to study 92kDa type IV collagenase transcription demonstrates that the NF-kappaB motif drives the transition from a repressed to an activated state of gene expression10.1096/fj.03-0960fje ↗
41. NF-kappaB-activated tissue transglutaminase is involved in ethanol-induced hepatic injury and the possible role of propolis in preventing fibrogenesis10.1016/j.tox.2008.01.009 ↗
42. The CC chemokine ligand, CCL2/MCP1, participates in macrophage fusion and foreign body giant cell formation10.1016/S0002-9440(10)63265-8 ↗
43. Decreasing TNF-alpha results in less fibrosis and earlier resolution of granulomatous experimental autoimmune thyroiditis10.1189/jlb.0606402 ↗
44. Systemic inhibition of NF-kappaB activation protects from silicosis10.1371/journal.pone.0005689 ↗
45. Murine FLIP transgene expressed on thyroid epithelial cells promotes resolution of granulomatous experimental autoimmune thyroiditis in DBA/1 mice10.2353/ajpath.2007.060816 ↗
46. Simultaneous transforming growth factor beta-tumor necrosis factor activation and cross-talk cause aberrant remodeling response and myocardial fibrosis in Timp3-deficient heart10.1074/jbc.M109.028449 ↗
47. Monocyte chemoattractant protein-1 (MCP-1): an overview10.1089/jir.2008.0027 ↗